Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis
Background: Relapses are common in patients with multiple sclerosis (MS) even after the use of disease-modifying therapies. Repository corticotropin injection (RCI), plasmapheresis (PMP), and intravenous immunoglobulin (IVIg) may be utilized as alternative therapies in the management of MS relapse....
Saved in:
Main Authors: | George J Wan (Author), Ishveen Chopra (Author), John Niewoehner (Author), Samuel F Hunter (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis
by: George J Wan, et al.
Published: (2021) -
Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis
by: Hunter SF, et al.
Published: (2021) -
Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis
by: Bindra J, et al.
Published: (2021) -
Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis
by: Howard Busch, et al.
Published: (2022) -
Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab
by: Knight T, et al.
Published: (2017)